Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)

v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Common Shares
Series1 Convertible Preferred Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020     $ 51,655,168 $ (50,731) $ (52,401,095) $ (796,658)
Balance at the beginning (in shares) at Dec. 31, 2020 4,828,846          
Changes in Shareholders' Equity (Deficit)            
Conversion of special warrants (in shares) 270,326          
Share-based compensation     397,480     397,480
Issuance of common shares, net of issuance costs of $1,665,099     15,867,936     15,867,936
Issuance of common shares, net of issuance costs of $1,665,099 (in shares) 2,096,357          
Foreign currency translation       (102,558)   (102,558)
Net loss         (7,545,497) (7,545,497)
Balance at the end at Sep. 30, 2021     67,920,584 (153,289) (59,946,592) 7,820,703
Balance at the end (in shares) at Sep. 30, 2021 7,195,529          
Balance at the beginning at Jun. 30, 2021     51,863,019 (195,948) (58,735,949) (7,068,878)
Balance at the beginning (in shares) at Jun. 30, 2021 5,099,172          
Changes in Shareholders' Equity (Deficit)            
Share-based compensation     189,629     189,629
Issuance of common shares, net of issuance costs of $1,665,099     15,867,936     15,867,936
Issuance of common shares, net of issuance costs of $1,665,099 (in shares) 2,096,357          
Foreign currency translation       42,659   42,659
Net loss         (1,210,643) (1,210,643)
Balance at the end at Sep. 30, 2021     67,920,584 (153,289) (59,946,592) 7,820,703
Balance at the end (in shares) at Sep. 30, 2021 7,195,529          
Balance at the beginning at Dec. 31, 2021     68,039,178 (187,919) (62,191,201) $ 5,660,058
Balance at the beginning (in shares) at Dec. 31, 2021 7,195,529         7,195,529
Changes in Shareholders' Equity (Deficit)            
Share-based compensation     348,861     $ 348,861
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares     5,600,000     5,600,000
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares (in shares)   70,000,000        
Foreign currency translation       (82,397)   (82,397)
Net loss         (10,796,758) (10,796,758)
Balance at the end at Sep. 30, 2022     73,988,039 (270,316) (72,987,959) $ 729,764
Balance at the end (in shares) at Sep. 30, 2022 7,195,529 70,000,000       7,195,529
Balance at the beginning at Jun. 30, 2022     73,879,455 (138,442) (67,031,084) $ 6,709,929
Balance at the beginning (in shares) at Jun. 30, 2022 7,195,529 70,000,000        
Changes in Shareholders' Equity (Deficit)            
Share-based compensation     108,584     108,584
Foreign currency translation       (131,874)   (131,874)
Net loss         (5,956,875) (5,956,875)
Balance at the end at Sep. 30, 2022     $ 73,988,039 $ (270,316) $ (72,987,959) $ 729,764
Balance at the end (in shares) at Sep. 30, 2022 7,195,529 70,000,000       7,195,529